Form 2L IRB at Signatory Institution

NIH NCI Central Institutional Review Board (CIRB) Initiative (NCI)

2L_IRB at SI_REV

IRB at Signatory Institution (Attach 2L)

OMB: 0925-0625

Document [docx]
Download: docx | pdf

IRB at Signatory Institution

(All contact forms must be submitted by the local IRB of the signatory institution.)


OMB#: 0925 – 0625

Expiry Date: 01/31/2014

Collection of this information is authorized by The Public Health Service Act, Section 411 (42 USC 285a). Rights of your participation in the National Cancer Institute (NCI) Central Institutional Review Board (CIRB) Initiative is protected by The Privacy Act of 1974, as amended. The purpose of the information collection is to conduct reviews of clinical trial studies. Although your participation in NCI-sponsored research and completion of the forms is voluntary, if you wish to participate in the CIRB, you must complete all questions on the form. The information you provide will be combined for all participants and reported as summaries. It will be kept private to the extent provided by law.

NOTIFICATION TO RESPONDENT OF ESTIMATED BURDEN

Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0625). Do not return the completed form to this address.

 



Please list IRB(s) at your signatory institution that currently review Pediatric and/or Adult Cooperative Group cancer treatment studies. Be sure to supply the OHRP IRB Registration Number for each IRB and whether each IRB will be reviewing Adult or Pediatric Cooperative Group treatment studies or both.


Add Revise

IRB Information at Signatory Institution

Institution Name      

IRB Name      

OHRP IRB Registration Number      

Review Type (Adult, Pediatric, Both)

Will this IRB have authority to perform facilitated review? (Yes, No)

Is this IRB the IRB of Record for an entire Community Clinical Oncology Program (CCOP)? (Yes/No)

Name of CCOP      

Does this IRB serve as the IRB of Record for a participating CCOP institution? (Yes/No)

Name of CCOP      

Is this IRB the IRB of Record for an entire for a Minority-Based Community Clinical Oncology Program (MBCCOP)? (Yes/No)

Name of MBCCOP      

Does this IRB serve as the IRB of Record for a participating MBCCOP institution? (Yes/No)

Name of MBCCOP      

Does this IRB serve as the IRB of record for an NCI-designated Cancer Center? (Yes/No)

Name of Cancer Center      

Does this IRB review adult Cooperative Group phase 3 and/or pediatric phase 2, 3 or pilot studies for a college, university, or medical school? (Yes/No)

Name of College, University, or Medical School

     


Remove IRB(s)

IRB Name

IRB Registration Number

     

     

     

     

     

     


(Internal use only)

Site GUID

     

TABLE

IRB


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleNew Signatory IRB
AuthorBrian Campbell
File Modified0000-00-00
File Created2021-01-28

© 2024 OMB.report | Privacy Policy